MYB and ovarian carcinoma: Overexpression of c-Myb in ovarian cancer tissues often leads to a poor prognosis, since c-Myb activates NF-κB and the STAT-3 signaling pathway, which promotes tumor growth, invasion and chemotherapy resistance.